Department of Neurology Grants
Investigator: Joseph Berger, MD PI: Yes
Sponsored By: Vanderbilt University
CNS Viral Dynamics and Cellular Immunity During AIDS
Start: 5/1/2006 End: 4/30/2007
Investigator: John Slevin, MD PI: Yes
Sponsored By: UCB Pharma
Effect of Levetiracetam on SNARE complex Assembly During Epileptogenesis
Co-Investigator: Thomas Vanaman, PhD
Co-Investigator: Sidney Whiteheart, PhD
Start: 3/20/2006 End: 3/19/2007
Investigator: Meriem Bensalem-Owen, MD PI: No
Sponsored By: Quintiles Inc
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study to Determine the Efficacy and Safety of Retigabine (1200 mg/day) Used as Adjunctive Therapy in Refractory Epilepsy Patients with Partial-Onset Seizures
Co-Investigator: Toufic Fakhoury, MD
Start: 3/1/2006 End: 2/28/2007
Investigator: Arman Sabet, MD PI: Yes
Sponsored By: Michael I Weintraub, MD
Bi-Azial, Rotating, Magnetic Field Therapy in Diabetic Peripheral Neuropathy: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial
Start: 3/1/2006 End: 2/28/2007
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: Quintiles Inc
A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel-Group Phase 3 Study to Determine the Efficacy and Safety of Retigabine (1200 mg/day) Used as Adjunctive Therapy in Refractory Epilepsy Patients with Partial-Onset Seizures
Co-Investigator: Meriem Bensalem-Owen, MD
Start: 3/1/2006 End: 2/28/2007
Investigator: Anand Vaishnav, MD PI: Yes
Sponsored By: Novo Nordisk Pharmaceuticals Inc
Trial of Activated Recombinant Factor VII (NovoSeven/Niastase) in Acute Intracerebral Haemorrhage
Co-Investigator: L. Creed Pettigrew, MD, MPH
Co-Investigator: Neil Troffkin, MD
Start: 1/1/2006 End: 12/31/2006
Investigator: Edward Kasarskis, MD, PhD PI: Yes
Sponsored By: ALS Association
ALS Research Group DNA Banking Study
Start: 1/1/2006 End: 12/31/2007
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: GlaxoSmithKline
An Open Label, Double Conversion Study to Characterize the Pharmacokinetics of Lamtrigine When Switching Patients with Epilepsy on Lamictal Immediate-Release to Extended-Release Formulation and Vice Versa
Start: 1/1/2006 End: 12/31/2006
Investigator: Franca Cambi, MD PI: Yes
Sponsored By: ELA Conseil Scientifique
Correcting PLP Driven Myelin Deficiencies: Cellular Approaches to Restore a Normal Phentoype
Start: 11/1/2005 End: 10/31/2006
Investigator: Joseph Berger, MD PI: Yes
Sponsored By: Berlex Laboratories Inc
Subtle Abnormalities in Normal Appearing White Matter of Relapsing-Remitting MS Patients and the Responses to Interferon-Beta: A Pilot Study
Start: 10/25/2005 End: 3/30/2006
Investigator: John Slevin, MD PI: Yes
Sponsored By: AMGen
A Multi-Center, Observational Safety Registry of Subjects with Idiopathic Parkinson's Disease Previously Treated with Intraputaminal Infusion of Liatermin
Start: 10/4/2005 End: 9/30/2007
Investigator: Michael Reid, PhD PI: False
Sponsored By: National Space Biomedical Research Institute
Redox Modulation of Muscle Function in Microgravity
Co-Investigator: Arman Sabet, MD
Start: 9/1/2005 End: 8/31/2006
Investigator: Franca Cambi, MD PI: Yes
Sponsored By: Alfred I Dupont Hospital for Children
Center for Pediatric Research
Start: 8/1/2005 End: 7/31/2006
Investigator: William Maragos, MD, PhD PI: Yes
Sponsored By: American Heart Association
Targeted Mitochondrial Uncoupling in Focal Cerebral Ischemia
Start: 7/1/2005 End: 6/30/2006
Investigator: Charles Smith, MD PI: No
Sponsored By: KY Health Services Cabinet
Dementia Outreach Lexington: Diagnosis/Treatment and Services for African-Americans
Start: 7/1/2005 End: 6/30/2006
Investigator: Edward Kasarskis, MD, PhD PI: Yes
Sponsored By: ALS Association
Emotional Disclosure in Patients with Amyotrophic Lateral Sclerosis: A Randomized, Controlled Trial
Co-Investigator: Alyssa Averill, MS
Co-Investigator: Suzanne Segerstrom, PhD
Start: 6/1/2005 End: 8/15/2006
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: Eisai Medical Research Inc
A Double-Blind, Placebo-Controlled, Dose-Escalation, Parallel-Group Study of E2007 Given as Adjunctive Therapy in Patients with Refractory Partial Seizures
Start: 4/18/2005 End: 4/30/2007
Investigator: Ashok Chauhan, PhD PI: False
Sponsored By: KY Spinal Cord and Head Injury Research Trust
Calpain as a Therapeutic Target Following Spinal Cord Injury
Start: 1/15/2005 End: 1/14/2007
Investigator: L. Creed Pettigrew, MD, MPH PI: Yes
Sponsored By: Daiichi Pharmaceuticals
Dose Finding Study of The Safety and Efficay of Sun N4057 (PICLOZOTAN)
Co-Investigator: Anand Vaishnav, MD
Start: 1/1/2005 End: 1/31/2007
Investigator: Kevin Nelson, MD PI: Yes
Sponsored By: Allegran Pharmaceuticals
Placebo Controlled Trial of BOTOX versus Zanaflex for the Treatment of Subjects with Post-Stroke Upper Limb Spasticity
Start: 1/1/2005 End: 12/31/2006
Investigator: John Slevin, MD PI: Yes
Sponsored By: Boston University
Genetic Linkage Study in Parkinson's Disease
Start: 11/1/2004 End: 7/31/2007
Investigator: William Robertson, Jr, MD PI: No
Sponsored By: Abbott Laboratories
An Open Label, Multicenter Study of the Long Term Safety of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in children, Protocol M04-714
Co-Investigator: Robert Baumann, MD
Start: 11/1/2004 End: 10/31/2006
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: Abbott Laboratories
An Open Label, Multicenter Study of the Long Term Safety of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
Co-Investigator: Robert Baumann, MD
Co-Investigator: William Robertson, Jr, MD
Start: 11/1/2004 End: 10/31/2006
Investigator: Robert Baumann, MD PI: No
Sponsored By: Abbott Laboratories
An Open Label, Multicenter Study of the Long Term Safety of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
Co-Investigator: Toufic Fakhoury, MD
Start: 11/1/2004 End: 10/31/2006
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: Schwarz BioSciences Inc
An Open Label-Extension Trial to Determine Safety and Efficacy of Long Term SPM 927 in Patients with Partial Seizures
Start: 10/14/2004 End: 1/31/2007
Investigator: L. Creed Pettigrew, MD, MPH PI: Yes
Sponsored By: Yale University
Insulin Intervention after Stroke (IRIS) Trial
Start: 9/15/2004 End: 6/30/2006
Investigator: Anand Vaishnav, MD PI: Yes
Sponsored By: Boehringer Ingelheim
Prevention Regimen for Effectively Avoiding Second Strokes: A Double-Blind, Active and Placebo-Controlled Study of Aggrenox vs. Clopidogrel + Aspirin, With and Without Micardis (PRoFESS)
Co-Investigator: L. Creed Pettigrew, MD, MPH
Start: 6/1/2004 End: 9/30/2007
Investigator: Franca Cambi, MD PI: Yes
Sponsored By: National Institute of Child Health and Human Development
PLP Splicing in Vivo Analysis in a Mouse Model
Start: 5/25/2004 End: 2/28/2007
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: Scirex
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (400 and 600mg/day) as Adjunctive Therapy in Subjects with Partial Seizures with or without Secondary Generalization
Start: 5/1/2004 End: 1/31/2007
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: GlaxoSmithKline
LAM40124 An Assesment of Behavioral Changes Associated with Lamotrigine and Levetiracetam in Patients with Epilepsy
Start: 1/21/2004 End: 1/31/2007
Investigator: Anand Vaishnav, MD PI: No
Sponsored By: AGA Medical Co
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial)
Co-Investigator: John Gurley, MD
Start: 1/5/2004 End: 12/31/2006
Investigator: L. Creed Pettigrew, MD, MPH PI: Yes
Sponsored By: AGA Medical Co
Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT Trial)
Co-Investigator: Anand Vaishnav, MD
Co-Investigator: John Gurley, MD
Start: 1/5/2004 End: 12/31/2006
Investigator: Anand Vaishnav, MD PI: Yes
Sponsored By: Univeristy of Texas Health Science Center
Secondary Prevention of Small Subcortical Strokes (SPS3)
Co-Investigator: L. Creed Pettigrew, MD, MPH
Co-Investigator: Paolo Fanti, MD
Start: 11/1/2003 End: 1/31/2007
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: Abbott Laboratories
A Randomized Double Blind Parallel Group Multicenter Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
Start: 11/1/2003 End: 2/28/2007
Investigator: Joseph Berger, MD PI: Yes
Sponsored By: National Institute of Dental Research
JCV Virus Expression in Oropharnyx and HIV
Co-Investigator: Craig Miller, DMD, MS
Start: 7/1/2003 End: 6/30/2006
Investigator: Toufic Fakhoury, MD PI: Yes
Sponsored By: Schwarz BioSciences Inc
A Multicenter Double-Blind Randomized Placebo-Controlled Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/day, 600mg/day) as Adjunctive Therapy in Subjects With Partial Seizures with or without Secondary Generalization
Start: 5/5/2003 End: 2/28/2007
Investigator: Charles Smith, MD PI: Yes
Sponsored By: National Institute of Mental Health
Neuroimaging of Shape Similarity in Object Recognition
Co-Investigator: Peter Hardy, PhD
Start: 4/1/2003 End: 3/31/2007
Investigator: Houta Sabet, PhD PI: False
Sponsored By: University of Medicaine and Dentistry of NJ
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Study
Co-Investigator: Vivian Abascal, MD
Start: 8/1/2002 End: 7/31/2006
Investigator: L. Creed Pettigrew, MD, MPH PI: Yes
Sponsored By: University of Medicaine and Dentistry of NJ
Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction Study
Co-Investigator: Houta Sabet, PhD
Co-Investigator: Vivian Abascal, MD
Start: 8/1/2002 End: 7/31/2006
Investigator: John Slevin, MD PI: Yes
Sponsored By: AMGen
Within Subject, Dose-Escalation Trial of Continuously Infused Intraputamental (Ipu) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor for the Treatment of Subjects with Idiopathic Parkinson's Disease
Start: 5/23/2002 End: 12/31/2006
Investigator: William Maragos, MD, PhD PI: Yes
Sponsored By: National Institute on Drug Abuse
Methamphetamine and HIV Protein-Induced Neurotoxicity
Co-Investigator: Wayne Cass, PhD
Start: 2/15/2001 End: 12/31/2006
Investigator: L. Creed Pettigrew, MD, MPH PI: Yes
Sponsored By: Mayo Foundation
Siblings with Ischemic Stroke (SWISS)
Start: 10/1/2000 End: 6/30/2006
Investigator: Avindra Nath, MD PI: False
Sponsored By: National Institute on Drug Abuse
Opiates: Neuronal and Glial Vulnerability to HIV
Co-Investigator: Rosemarie Booze, PhD
Start: 9/30/2000 End: 7/31/2006
Investigator: Joseph Berger, MD PI: Yes
Sponsored By: National Institute of Deafness & Other Communications
MR Predictors of Response to HAART in HIV Dementia
Start: 9/26/2000 End: 8/31/2006 |
|
